Abstract:Gestational trophoblastic diseases (GTD) encompass a spectrum of rare pre-malignant and malignant entities originating from trophoblastic tissue. This updated review will highlight important radiological features, pathology and classification, and provide insight into the clinical management of these uncommon disorders. There is a wide geographic variation with the incidence of hydatidiform mole varying between 0.57 and 2 per 1000 pregnancies. The use of ultrasound (US) in the management of early pregnancy symptoms and complications has positively impacted the earlier detection of these diseases and resulted in diminished morbidity. Additional imaging modalities are reserved for problem solving or assessment of pulmonary manifestations of molar pregnancy. Having an awareness of their pleomorphic sonographic presentation and additional pathology that can mimic GTD is critical to avoiding pitfalls. Histologic and molecular analysis further aids in differential diagnosis. Gestational trophoblastic neoplasia (GTN) is inclusive of all malignant GTDs, and arises after 20% of molar pregnancies but can also be seen with non-molar gestations. Biochemical monitoring with human chorionic gonadotrophin is imperative for ongoing monitoring and surveillance and allows early detection of this entity. Doppler US is used for confirmation of diagnosis with magnetic resonance imaging (MRI) reserved for problem solving or assessment of myometrial invasion. This is of heightened relevance in patients undergoing surgical management. Cross sectional imaging is reserved for patients in the setting of GTN for the purposes of staging, prognostication and in the setting of recurrent disease. This may require a combination of computed tomography, MRI and positron emission tomography. Doppler US can provide insight into chemotherapeutic response/predict resistance in patients with GTN. As our understanding of these disorders evolves, there has been maturation in management options with a shift from traditional chemotherapy to innovative immunotherapy, particularly in the setting of resistant or high-risk disease.

Diagnosis and Treatment of Gestational Trophoblastic Neoplasia

Diagnosis and management of or recurrent resistant gestational trophoblastic neoplasia

Clinical analysis of recurrent gestational trophoblastic neoplasia

Management of brain metastases in gestational trophoblastic neoplasia

Diagnosis and management of gestational trophoblastic disease: 2021 update

Update on the diagnosis and management of gestational trophoblastic disease

Development in clinical diagnosis of gestational trophoblastic tumors

Advances in diagnostics and management of gestational trophoblastic disease

Gestational Trophoblastic Neoplasia with Extrauterine Metastasis but Lacked Uterine Primary Lesions: a Single Center Experience and Literature Review

Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy

Gestational trophoblastic disease: an update

Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.

Management and Prognostic Analysis of Patients with Gestational Trophoblastic Neoplasia (GTN) in FIGO Stage IV and Its Special Type

Current chemotherapeutic options for the treatment of gestational trophoblastic disease

Management of trophoblastic tumors : review of evidence, current practice, and future directions

Clinical Analysis of 13 Cases of Gestational Trophoblastic Tumor Misdiagnosed As Ectopic Pregnancy

Review of current literature on gestational trophoblastic neoplasia

Explore the Non-mole Gestational Trophoblastic Tumor by Reviewing 62 Clinical Cases

[Curative Effects and Influenced Factors of Primary Chemotherapy with Single-Agent Methotrexate on Low-Risk Gestational Trophoblastic Neoplasia].

Pathology of Gestational Trophoblastic Disease (GTD)

Diagnosis and treatment of epithelioid trophoblastic tumor